P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e530118d-n/a
Main Authors: Huang, Jian, Zhang, Xinlu, Feng, Weiying, Qian, Honglan, Yu, Chen, Liu, Lirong, Chen, Dan, Zhu, Xiaoqiong, Wang, Huafeng, Yang, Xiudi, Zhu, Jingjing, Wu, Dijiong, Zhou, Mei, Lu, Ying, Wang, Yi, Tong, Hongyan, Jin, Jie
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S3
container_start_page e530118d
container_title HemaSphere
container_volume 7
creator Huang, Jian
Zhang, Xinlu
Feng, Weiying
Qian, Honglan
Yu, Chen
Liu, Lirong
Chen, Dan
Zhu, Xiaoqiong
Wang, Huafeng
Yang, Xiudi
Zhu, Jingjing
Wu, Dijiong
Zhou, Mei
Lu, Ying
Wang, Yi
Tong, Hongyan
Jin, Jie
description
doi_str_mv 10.1097/01.HS9.0000969640.53011.8d
format article
fullrecord <record><control><sourceid>wiley_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_206d87b0a5a0461e8c78ab864c9166d4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_206d87b0a5a0461e8c78ab864c9166d4</doaj_id><sourcerecordid>HEM3BF06757</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2857-67c1fe54e6c61dd9479541310b1610c041f251c21df6a497828241b6ec27ffb83</originalsourceid><addsrcrecordid>eNqVks1u1DAUhSMEElXpO1jsZ_B1HP_MBqUZp7E6k4wSD6grK3GSkmraqZIW1B2P0IfgyXgS3A4CusQb-17f8x3LOkHwHvAcsOQfMMyzSs6xX5JJRvE8CjHAXLSvgiMScTKThMLrf85vg5NpuvLzIKVkhB8FPzZM0AWK0Xq7MjpRuVElKpUpi2qjEqM_KVSZ7fIC6Rwlmc7jBUpWOtdJvPJ1XMaJF-jKSysU50u0KYuzvKh0hYoUbWKjPbFCn7XJULJe_fz-mGyQKVVs1PLQXeo0VaWfQubCm-pcoXNvUynvmOlTbYqyehe86evd1J383o-DbapMks1WxdnTS2aOiIjPGHfQdxHtmGPQtpJyGVEIATfAADtMoScROAJtz2oquSDC_0nDOkd43zciPA70gdvu6yt7Ow7X9fhg9_Vgnxv78dLW493gdp0lmLWCN7iOakwZdMJxUTeCUSeBsZZ61scD6_a-ue5a193cjfXuBfTlzc3wxV7uv1rAlEjGsScsDgQ37qdp7Po_YsD2KQAWg_UBsH8DYJ8DYEXrxclB_G3YdQ__obSZWoenKWY84uEvcL6sEg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS</title><source>Open Access: PubMed Central</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Huang, Jian ; Zhang, Xinlu ; Feng, Weiying ; Qian, Honglan ; Yu, Chen ; Liu, Lirong ; Chen, Dan ; Zhu, Xiaoqiong ; Wang, Huafeng ; Yang, Xiudi ; Zhu, Jingjing ; Wu, Dijiong ; Zhou, Mei ; Lu, Ying ; Wang, Yi ; Tong, Hongyan ; Jin, Jie</creator><creatorcontrib>Huang, Jian ; Zhang, Xinlu ; Feng, Weiying ; Qian, Honglan ; Yu, Chen ; Liu, Lirong ; Chen, Dan ; Zhu, Xiaoqiong ; Wang, Huafeng ; Yang, Xiudi ; Zhu, Jingjing ; Wu, Dijiong ; Zhou, Mei ; Lu, Ying ; Wang, Yi ; Tong, Hongyan ; Jin, Jie</creatorcontrib><identifier>ISSN: 2572-9241</identifier><identifier>EISSN: 2572-9241</identifier><identifier>DOI: 10.1097/01.HS9.0000969640.53011.8d</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins</publisher><ispartof>HemaSphere, 2023-08, Vol.7 (S3), p.e530118d-n/a</ispartof><rights>Copyright © 2023 The Author(s).</rights><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429670/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429670/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,27903,27904,46030,46454,53769,53771</link.rule.ids></links><search><creatorcontrib>Huang, Jian</creatorcontrib><creatorcontrib>Zhang, Xinlu</creatorcontrib><creatorcontrib>Feng, Weiying</creatorcontrib><creatorcontrib>Qian, Honglan</creatorcontrib><creatorcontrib>Yu, Chen</creatorcontrib><creatorcontrib>Liu, Lirong</creatorcontrib><creatorcontrib>Chen, Dan</creatorcontrib><creatorcontrib>Zhu, Xiaoqiong</creatorcontrib><creatorcontrib>Wang, Huafeng</creatorcontrib><creatorcontrib>Yang, Xiudi</creatorcontrib><creatorcontrib>Zhu, Jingjing</creatorcontrib><creatorcontrib>Wu, Dijiong</creatorcontrib><creatorcontrib>Zhou, Mei</creatorcontrib><creatorcontrib>Lu, Ying</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Tong, Hongyan</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><title>P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS</title><title>HemaSphere</title><issn>2572-9241</issn><issn>2572-9241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqVks1u1DAUhSMEElXpO1jsZ_B1HP_MBqUZp7E6k4wSD6grK3GSkmraqZIW1B2P0IfgyXgS3A4CusQb-17f8x3LOkHwHvAcsOQfMMyzSs6xX5JJRvE8CjHAXLSvgiMScTKThMLrf85vg5NpuvLzIKVkhB8FPzZM0AWK0Xq7MjpRuVElKpUpi2qjEqM_KVSZ7fIC6Rwlmc7jBUpWOtdJvPJ1XMaJF-jKSysU50u0KYuzvKh0hYoUbWKjPbFCn7XJULJe_fz-mGyQKVVs1PLQXeo0VaWfQubCm-pcoXNvUynvmOlTbYqyehe86evd1J383o-DbapMks1WxdnTS2aOiIjPGHfQdxHtmGPQtpJyGVEIATfAADtMoScROAJtz2oquSDC_0nDOkd43zciPA70gdvu6yt7Ow7X9fhg9_Vgnxv78dLW493gdp0lmLWCN7iOakwZdMJxUTeCUSeBsZZ61scD6_a-ue5a193cjfXuBfTlzc3wxV7uv1rAlEjGsScsDgQ37qdp7Po_YsD2KQAWg_UBsH8DYJ8DYEXrxclB_G3YdQ__obSZWoenKWY84uEvcL6sEg</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>Huang, Jian</creator><creator>Zhang, Xinlu</creator><creator>Feng, Weiying</creator><creator>Qian, Honglan</creator><creator>Yu, Chen</creator><creator>Liu, Lirong</creator><creator>Chen, Dan</creator><creator>Zhu, Xiaoqiong</creator><creator>Wang, Huafeng</creator><creator>Yang, Xiudi</creator><creator>Zhu, Jingjing</creator><creator>Wu, Dijiong</creator><creator>Zhou, Mei</creator><creator>Lu, Ying</creator><creator>Wang, Yi</creator><creator>Tong, Hongyan</creator><creator>Jin, Jie</creator><general>Lippincott Williams &amp; Wilkins</general><general>Wiley</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230808</creationdate><title>P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS</title><author>Huang, Jian ; Zhang, Xinlu ; Feng, Weiying ; Qian, Honglan ; Yu, Chen ; Liu, Lirong ; Chen, Dan ; Zhu, Xiaoqiong ; Wang, Huafeng ; Yang, Xiudi ; Zhu, Jingjing ; Wu, Dijiong ; Zhou, Mei ; Lu, Ying ; Wang, Yi ; Tong, Hongyan ; Jin, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2857-67c1fe54e6c61dd9479541310b1610c041f251c21df6a497828241b6ec27ffb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Jian</creatorcontrib><creatorcontrib>Zhang, Xinlu</creatorcontrib><creatorcontrib>Feng, Weiying</creatorcontrib><creatorcontrib>Qian, Honglan</creatorcontrib><creatorcontrib>Yu, Chen</creatorcontrib><creatorcontrib>Liu, Lirong</creatorcontrib><creatorcontrib>Chen, Dan</creatorcontrib><creatorcontrib>Zhu, Xiaoqiong</creatorcontrib><creatorcontrib>Wang, Huafeng</creatorcontrib><creatorcontrib>Yang, Xiudi</creatorcontrib><creatorcontrib>Zhu, Jingjing</creatorcontrib><creatorcontrib>Wu, Dijiong</creatorcontrib><creatorcontrib>Zhou, Mei</creatorcontrib><creatorcontrib>Lu, Ying</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Tong, Hongyan</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>HemaSphere</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Jian</au><au>Zhang, Xinlu</au><au>Feng, Weiying</au><au>Qian, Honglan</au><au>Yu, Chen</au><au>Liu, Lirong</au><au>Chen, Dan</au><au>Zhu, Xiaoqiong</au><au>Wang, Huafeng</au><au>Yang, Xiudi</au><au>Zhu, Jingjing</au><au>Wu, Dijiong</au><au>Zhou, Mei</au><au>Lu, Ying</au><au>Wang, Yi</au><au>Tong, Hongyan</au><au>Jin, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS</atitle><jtitle>HemaSphere</jtitle><date>2023-08-08</date><risdate>2023</risdate><volume>7</volume><issue>S3</issue><spage>e530118d</spage><epage>n/a</epage><pages>e530118d-n/a</pages><issn>2572-9241</issn><eissn>2572-9241</eissn><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1097/01.HS9.0000969640.53011.8d</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2572-9241
ispartof HemaSphere, 2023-08, Vol.7 (S3), p.e530118d-n/a
issn 2572-9241
2572-9241
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_206d87b0a5a0461e8c78ab864c9166d4
source Open Access: PubMed Central; Open Access: Wiley-Blackwell Open Access Journals
title P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A41%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P684:%20A%20MULTICENTER%20RETROSPECTIVE%20STUDY%20IN%20CHINA:%20CLINICAL%20CHARACTERISTICS%20AND%20PROGNOSIS%20OF%20PATIENTS%20WITH%20CML%E2%80%90CP%20TREATED%20WITH%20DIFFERENT%20TYROSINE%20KINASE%20INHIBITORS&rft.jtitle=HemaSphere&rft.au=Huang,%20Jian&rft.date=2023-08-08&rft.volume=7&rft.issue=S3&rft.spage=e530118d&rft.epage=n/a&rft.pages=e530118d-n/a&rft.issn=2572-9241&rft.eissn=2572-9241&rft_id=info:doi/10.1097/01.HS9.0000969640.53011.8d&rft_dat=%3Cwiley_doaj_%3EHEM3BF06757%3C/wiley_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2857-67c1fe54e6c61dd9479541310b1610c041f251c21df6a497828241b6ec27ffb83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true